<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 210 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page209.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=210">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 210 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 210</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=210"><img src="../thumb/210.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Gastro-Intestinal Tract - 12.4.3 / 12.4.4                                      2020-04 / 175
       Dosage: Admin IV/IM.Tot.dly.dos.not to exceed 2,4 g.Usual.dos:   Special precautions: Excl.poss.malign.bef.ther., ren.impairm., pe-  (S4) POWD.FOR SOL.FOR INJ, 44/11.4.3/0981. 40 mg
       200 mg repeat.4-6 hrly. Admin.IVI slow.over 2 mins. IV infus.recomm.  riod.exam.dur.longterm treatm., concom. NSAID esp.elderly, CV dis.,   720385-002: 1x15 ml, R31,93
       if larg.dos. reqd. or in CV impairm. Intermitt.IV infus: recomm. dos. is   cross.placenta & pass.into breast milk, limit.exper.in childr., evid. in-  720385-001: 5x15 ml, R159,73
       400 mg in 100 ml NaCl 0,9% sol.over 30-60 mins.& repeat.4-6 hrly if   dic.protect.aginst NSAID assoc.ulcerat.in duodenum & not stomach.  Dosage: Only for IV use for up to 7 days in pts. who cannot be treat.
       necess. Recomm.rate for contin.IV infus: 50-100 mg/hr.  Drug interactions: Poss.decr.absorpt.with antacids.  oral. Replac.ther.by same oral dos.in compliance with approv.dos.
       Childr: Only if benef.outweighs potent.risk. Limit. exper: 20-40 mg/  regim.as soon as poss. Once reconstit.admin.by direct.IV or dil. furth.
       kg/day in div.dos.                                         with 100 ml 0,9% NaCl or 5% gluc.only. Admin. over 2-15 mins.
       CV impairm: IV infus.recomm.                               Duod.ulc: 40 mg once dly. Use in combinat.with appropr.antibiot.
       Contraindications: Safety in pregn.& lactat.not est., infts.und.1 yr. 12.4.4   Proton pump inhibitors  when assoc.with H.Pylori.
       Side effects: Diarrh., dizzin., tiredn., headache, rash., confus.states   Gastr.ulc: 40 mg once dly..
       esp.in elderly/ser.ill pts.incl. ren.fail., gynaecomast., impot., hyper-  TRUSTAN (MDR Listing)  Reflux oesophagit: 40 mg once dly.
       sens.reacts., fev., arthralg., myalg., bld.dycras., interstit. nephrit.,   ACCORD OMEPRAZOLE, Accord [P/S]  Zollinger-Ellison syndr: Init.80 mg dly theraft. titrat.up/ down as
       hepatotox., CV disords.       Omeprazole                   need. Dos.above 80 mg to be div.& admin.2x dly.
       Special precautions: Excl.poss.malign.bef.init. treatm., imp.  Indications: Short term treatm.of duod.ulc./ gastr.ulc./reflux oe-  If rapid acid contr.is req.a start.dos.of 2 x 80 mg is suffic.to man-
       ren.funct., limit.exper.in childr., cross. placent.barrier & excret.  sophagit. & Zollinger-Ellison syndr.when oral ther.inapprop/contra-  age a decr.of acid output into target range (&lt;10 mEq/h) within 1
       into breast milk.             indicat.for max.5 days.      hr in maj.of pts.
       Drug interactions: Poss.dos.reduct.of cyclospor./ lignocaine/nifedi-  (S4) POWD.FOR SOL FOR INFUS, 41/11.4.3/0663  Mild to mod.liv.impairm: Do not exceed 20 mg dly.
       pine/phenytoin/suxamethonium/ theophyll./warfarin.  715885-001: 40 mg, 1xvial, R42,24  Contraindications: Safety & effic.in pregn.& lactat. & in childr.not
       R-LOC INJECTION, Zydus [P/S]  Dosage: Reconstit.with 100 ml 5% gluc.& admin. as IV infus.  est., sev.liv.funct.impairm., concom. atazanavir/nelfinavir.
                                                                  Side effects: Bld.dyscras., tinnit., vertigo, blurr. vis., anter.ischaem.
       Ranitidine HCl.               over 20-30 mins.             optic neuropathy, GI disturbs. incl. pancreatit./stomatit., fatig., throm-
       Indications: Duod.ulc., benign gastr.ulc., reflux oesophagit.,   Recomm.dos: IV infus of 40 mg as dly dos. Indiv. dos.for Zollinger-  bophlebit., asthen., sweat., malaise, sev.hepatocell.damage lead.
       Zollinger-Ellison syndr., anaesthes. pre-med.to reduc. vol.& acid   Ellison when high.dos.may be indicat. If dos.exceeds 60 mg dly.div.  to jaund.with/without hepat.fail., incr.liv. enzym., hepatit., hepat.
       content of gastr. secret.minimis.acid aspirat.syndr.  dos.& admin. 2xdly.infus.  encephalopathy, anaphylact. reacts., allerg.reacts.incl.prurit./skin
       (S3) INJ, 37/11.4.3/0266. 50 mg/2 ml.  Contraindications: Safety in pregn.& lactat.not est.  rash/urticar./angioed., UTI, URTI, incr.triglycerid., incr. body temp.,
       704786-001: 5x2 ml, R226,30   Side effects: Headache, CNS effs., paraesthes., depress., aggres-  hyperglycaem., arthralg., myalg., rhabdomyolys., hyperton., headache,
       Dosage: Admin.IV/IM.          siven., hallucinat., vertigo, ment. confus., agitat., GI disturbs., dry   paraesthes., dizzin., hypokines., speech disord., psych.disords. incl. de-
       Adults: Slow IVI(over 2 mins.)of 50 mg dil.to vol.of 20 ml may be   mouth, stomatit., candidias., taste disturbs., incr.liv.enzymes, hepatit.   press./revers.confus.state/agitat./ hallucinat, interstit.nephrit., impot.,
       rep. 6-8 hrly.or IV.infus.at rate of 25 mg/hr.x2 hrs. May be rep.at   with/without jaund., hepat.fail., photosens., blurr.vis., taste disturbs.,   gynaecomast., sev.skin reacts.incl.Stev.Johns./erythema multiforme/
       6-8 hrly.interv.              skin rash incl.erythema multiforme/Stev.John.syndr.& tox. epiderm.  tox.epiderm.necrolys., photosens., bullous erupt., alopec., periph.oed.
       Anaesth.pre-med: 50 mg IMI or 50 mg dil.to vol.of 20 ml by slow   necrolys., alopec., prurit., urticar., incr. sweat., gynaecomast., bld.  Warnings and special precautions: Excl.poss. malign., discont.
       IVI(over 2 mins) 45-60 mins prior to induct.  dyscras., hypersens. reacts., angio-oed., fev., bronchosp., interstit.   ther.if liv.enzym.elev., confirm reflux. oesophag.diagn.by endoscopy,
       Contra-indications: Porphyr., pregn.& lactat., no exper.in child.  nephrit., anaphylact.shock, blurr.vis., periph.oed., hyponatraem., ma-  monit.for incr. INR/prothromb.time with warfarin.
       Side-effects: Bld.dyscras., bradycard.& AV block, headache, diz-  laise, arthralg.& mylag., musc. weakn., irrevers.vis. impairm.in critic.  Drug interactions: Reduc./incr.absorpt.of pH-depend. meds.
       zin., ment.confus., depress., hallucinat. (predom.elderly/sev.ill pts.),   ill receiv.high dos. bolus inj.  eg.ketoconazole,may prev. degradat. of acid-labile meds., poss.
       involun. motor disturbs., gynaecomast.in men, GI disturbs., hepato-  Special precautions: Excl.poss.malign., monit. concom. warfar.&   interacts.with meds. also metabol.via cytochrome P450 enzyme
       bil.effs.with/-out jaund., arthralg., myalg., skin rash incl.erythema   phenytoin, not recomm.in childr. as exper.limit., incr.freq.of benign   syst., decr.atazanavir/indinavir/nelfinavir conc., resp. to concom.
       multiforme, alopec., anaphylactoid reacts.  gastr.glandul. cysts with long-term treatm., poss.incr.GI infects.   anticoags.poss.affect.
       Special precautions: Excl.poss.malign., monit. anticoags.pro-  due to decr.acidity,
       thromb.time to prev.bleed.from anticoag. potent., incr.phenytoin   Drug interactions: Ketoconazole & itraconazole absorpt.reduc., elim-  ADCO-ROZNAL, AI Pharm [P/S]
       bld.conc., incr. assoc. atax.risk, cross.placenta & into breast milk,   in.of diazepam/warfar.& phenytoin prolong., plasma conc.of omepra-  Lansoprazole
       card.rhythm.disturbs., sev.ren.impairm., period. exam. pts.on pro-  zole & clarithromycin incr.with concom.admin., digox. bioavailabil.incr.  Indications: Short-term treatm.of gastric/duod. ulc. & reflux oe-
       long.maint.treatm.            ADCO-OMEPRAZOLE, AI Pharm Ltd [P/S]  sophagit., in conjunct.with appropr. antibiot.as part of eradicat.pro-
       Drug interactions: Eliminat.of meds.req.hepat. metabol.via cyto-  Omeprazole.  gram.for H.Pylori-posit.duod.ulc.
       chrome P450 system.poss.decr., procainamide bld.conc.incr.  Indications: Duod.ulc.incl.relap.prev., gastr.ulc., reflux oesophagit.  (S4) CAPS, 37/11.4.3/0558
       RANITIDINE 300 BIOTECH, Biotech [P/S]  incl.long-term managem., Zollinger-Ellison syndr., symptomat.heart-  704668-001: 30 mg, 28, R153,57
                                                                  Dosage:Take bef.meals.
       Ranitidine HCl                burn rel. in gastro-oesophag.reflux dis., short-term rel.of funct. dys-  Gastr.ulc: 30 mg once dly.for upto 8 wks.
       Indications: Duod.ulc., benign gastr.ulc.incl. prev. of duod.ulcerat.  peps., duod.ulc.assoc.with H.pylori infect. in combinat.with appropr.  Duod.ulc: 30 mg once dly.for upto 4 wks. As part of eradicat.pro-
       assoc.with NSAID’s use, reflux oesophagit., Zollinger-Ellison syndr.,   antibiot., NSAID assoc. gastric/duod.ulc./eros.& reduc.risk of de-  gram.with appropr.antibiot.for H.pylor posit.ulc.
       acid aspirat. syndr. risk dur.gen.anaesthes.  velop./ relapse of such assoc.ulc/eros., short term up to 3 mnths.  Oesophagit.due to gastro-oesophag.reflux: 30 mg once dly.x4
       (S3) TABS. 31/11.4.3/0674     treatm.of sev.ulcerat.reflux oesophagit.resist.to prev.treatm.in childr.  wks., rep.course poss.necess. depend. on endoscop.results
       718482-001: 300 mg, 30, R68,68  (S4) CAPS 37/11.4.3/0228   Contraindications: Pregn.& lactat., liv.impairm., safety & effic.
       Dosage: Peptic ulcerat: 150 mg 2xdly.or 300 mg at bedt.init.x4   703543-001: 20 mg, 28, R157,03  in childr.not est.
       wks. Ulc.not heal.within 4 wks.may need a furth.course. An 8-12   Dosage: Swallow whole in morn.with half glass water.  Do not   Side effects: Bld.dyscras., oed., CNS effs., GI disturbs.incl.ulcerat.
       wk.treatm.poss. necess. for NSAID assoc.ulc  chew/ crush.  colit., gynaecomast., galactorrh., elev.hepat.enzymes, asthen., ar-
       NSAID assoc.duod.ulc.prophylax: 150 mg 2xdly. dur NSAID ther.  Duod.ulc: 20 mg dly x2-4 wks. Pts.refract.to other treatm.regim:   thralg., myalg., blurr.vis., skin reacts., fev., incr.freq.of gastr. glandul.
       Reflux oesophagit: 150 mg 2xdly./300 mg at bedt. for up to 8-12   40 mg once dly may be effect.  cysts.dur long term treatm.& incr. gastric.bact.counts result.from in-
       wks. May be incr.to 150 mg 4xdly.for upto 12 wks.in mod.to sev.cases.  Relapse prev.& H.pylori posit.duod.ulc: 10 mg once dly.incr.to   hibit.of gastr. acid secret.
       Zollinger-Ellison syndr: Init: 150 mg 3xdly.incr.if necess.up to   20-40 mg dly.if necess. Also as part of eradicat.programme with ap-  Special precautions: Excl.malign., confirm. diagnos. by endoscopy,
       600-800 mg dly.               propr.antibiot. for H.Pylori assoc.ulc.  monit.concom.warfar.
       Anaesthes: 300 mg 2 hrs pre-op or 150 mg 12 hrs. prior follow.by   Gastr.ulc.& reflux oesophagit: 20 mg dly x4-8 wks. Pts.refract.to   Drug interactions: CNS depress.eff.enhanc.by CNS depress.& al-
       furth.150 mg 2 hrs. pre-op.   other treatm.regimens: 40 mg once dly.may be effect.  coh., poss.interacts.with drugs metabol. by cytochrome P450 syst.,
       Maint.treatm: In hist.of recurr.ulc.admin.150 mg dly at bedt. Ad-  Long term reflux oesophagit.treatm: 10 mg once dly incr.to 20-  warfar.conc. poss.reduc.
       dit.300 mg at bedt.to pts.unable to stop smok.  40 mg once dly.if need. If sev/ recurr.contin.with 20 mg dly.
       Contraindications: Porphyr.hist., safety in pregn. & lactat.not est..  NSAID assoc.gastroduod.les: 20 mg once dly. with heal.gen.with-  ALTOSEC, (Aspen Pharmacare: Pharma) Pharmacare [P/S] &
       Side effects: Trans.&revers.liv.funct.changes, hepatit.without   in 4 wks. If full heal.not achiev. aft.init.course contin.for furth.4 wks.  Omeprazole
       jaund., leucopen., thrombocytopen., agranulocytos., anaphylact. re-  NSAID assoc.prophylax: 20 mg once dly.  Indications: Duod.ulc.incl.relap.prev., gastr. ulc., reflux oeosphagit.
       acts., bradycard., AV block, headache, dizzin., ment.confus./depress   Symptomat.gastro-oesophag.reflux dis: 20 mg dly. Indiv.as some   incl.long term managem., Zollinger-Ellison syndr., gastro-oesophag.
       & hallucinat.main.in sev.ill/ elderly, GI disturbs., skin rash incl.ery-  may respond to 10 mg dly. Investig.furth.if sympt.control not achiev.  reflux dis. (GORD), 20 mg for H Pylori-pos.duod.ulc.in combin. with
       thema multiforme, ac.pancreatit., arthralg., myalg., breast sympt.&   aft.2 wks. on 20 mg dly.  appropr.antibiot.
       gynaecomast. in men.          Zollinger-Ellison syndr: 60 mg once dly. Adjust indiv.& contin.as   (S4) CAPS, 32/11.4.3/0703, 0087
       Special precautions: Excl.poss.malign.bef.ther., ren.impairm., pe-  long as indic. Dos.over 80 mg dly. admin.in 2 div.dos.  703988-001: 10 mg, 28, R184,40
       riod.exam.dur.longterm treatm., concom. NSAID esp.elderly,  Sev.ulcerat.reflux oesophagit.in childr.1 yr. & old: 10-20 kg:   703987-001: 20 mg, 28, R168,71
                                     10 mg once dly. &gt;20 kg: 20 mg once dly. If necess.incr.dos.to 20-  Dosage: Adults:
       ULTAK, Cipla Medpro [P/S]     40 mg respectiv.             Duod.ulc: 20 mg dly.x2-4 wks. In pts.refract.to other treatm.regimes:
       Ranitidine HCl                Contraindications: Safety in pregn.& lactat.not est., longt.safety   40 mg dly.may be effect. Prev.of relapse: 10 mg once dly.if necess.
       Indications: Duod.ulc., benign gastr.ulc.incl. prev.of duod.ulcerat.  in ren./hepat.impairm.not est.  incr.to 20-40 mg once dly. 20 mg caps are indic.for duod. ulc.assoc.
       assoc.with NSAID’s use, Zollinger-Ellison syndr., reflux oesophagit.,   Side effects: GI disturbs., stomatit., candidias., bld.dyscras., pho-  with H. Pylori infect.in combinat. with appropr.antibiot.
       acid aspirat.syndr.risk dur.gen.anaesthes.  tosens., skin rash incl.Stev. Johns. & tox.edpiderm.necrolys., hy-  Gastric ulc.& reflux oesophagit: 20 mg dly. x4-8 wks. When re-
       (S3) TABS. 32/11.4.3/0539,0540  ponatraem., bronchosp., headache, CNS effs., paraesthes., malaise,   fract.to other treatm.regimens 40 mg once dly.may be effect. Long-
       867934-018: 150 mg, 60, R99,06  fev., periph.oed., interstit.nephrit., gynaecomast., blurr.vis., hepatit.  term reflux oesophagit. mangem: 10 mg once dly.incr.to 20-40 mg
       867942-002: 300 mg, 30, R82,02  with/without jaund., hepat.encephalopathy, asthen., arthral.& my-  once dly.if necess. In sev./symptomat. recurr. reflux oesophagit.
       Dosage: Duod/gastr.ulc: 300 mg at bedt./ 150 mg 2xdly.init.x4 wks.   alg., hypersens.reacts.incl.anaphylax., taste disturbs., incr.sweat.,   contin.with 20 mg dly.
       Incr.dos.if necess.to max.300 mg 2xdly. Maint: 150 mg dly at bedt.   benign revers.gastr.glandul. cysts with long-term treatm., incr GI bact.  Symptomat.gastro-oesophag.reflux dis: Indiv. 10-20 mg once dly.
       Cont.for furth.4 wks. if not heal.  Special precautions: Cont.sucrose, excl.poss. malign., imp.hepat.  Investig.furth.if sympt. contr.not achiev.aft.4 wks.treatm.
       Reflux oesophagit: 150 mg 2xdly./300 mg at bedt.for up to 8-12 wks.  funct., limit.exper.in childr., monit. of INR/phenyt.serum lev., incr.GI   Zollinger-Ellison syndr: Init.60 mg dly. Indiv.& contin. as long as
       Zollinger-Ellison syndr: Init: 150 mg 2-3xdly. incr.if necess.up to   Salmonella & Campylobacter.infect. risk.  clinic.reqd. Effect.sev.dis. control. on 20-120 mg dly. Admin.dos.over
       600-800 mg dly.in div.dos.    Drug interactions: CNS depress.eff.enhanc.by CNS depress.& al-  80 mg dly.in 2 div.dos.
       Anaesthes: 300 mg 2 hrs pre-op or 150 mg 12 hrs.prior follow.by   coh., poss.interacts.with meds. also metabol.via cytochrome P450   Contraindications: Safety in pregn.not est.
       furth.150 mg 2 hrs. pre-op.   enzyme syst., poss.prolongs diazepam, warfarin & phenytoin elimi-  Side effects: Skin rash incl.erythema multiforme/ bull.erupt., pru-
       NSAID assoc.duod.ulc.prophylax: 150 mg 2xdly.dur NSAID ther.  nat., may incr.digox.bioavail.  rit., urticar., photosens., angio-oed., alopec., headache, GI disturbs.,
       Contraindications: Porphyr., ac.porphyr.hist., safety in pregn.&   stomatit., candidias., benign revers. gastr. glandul.cysts, bld.dyscras.,
       lactat.not est..              ADCO-PANTOPRAZOLE IV, AI Crit.Care [P/S]  CNS effs., revers. ment.confus., agitat., hallucinat., paraesthes., de-
       Side effects: CNS effs., GI disturbs., skin reacts. incl.erythema mul-  Pantoprazole  press., periph.oed., interstit. nephrit., gynaecomast., blurr.vis., taste
       tiforme, alopec., hepatit., jaund., bld. dyscras., anaphylactoid reacts.  Indications: Short-term treatm.of duod.& gastr. ulc. & reflux oe-  disturb., hepat. encephalopathy, hepatit.with/without jaund., hepat.
       incl.anaphylact. shock, bradycard., AV block, ac.pancreatit., arthralg.,   sophagit., duod.ulc.assoc.with H.pylori infect.in combinat.with ap-  fail., incr.liv.enzymes, myalg., incr. sweat., malaise, fev., bronchosp.,
       myalg., breast sympt., impot., gynaecomast. in men.  propr.antibiot., Zollinger-Ellison syndr.  arthritic sympts.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page209.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page205.html">205</a>&nbsp;&nbsp;&nbsp;<a href="page206.html">206</a>&nbsp;&nbsp;&nbsp;<a href="page207.html">207</a>&nbsp;&nbsp;&nbsp;<a href="page208.html">208</a>&nbsp;&nbsp;&nbsp;<a href="page209.html">209</a>&nbsp;&nbsp;&nbsp;<a href="page210.html">210</a>&nbsp;&nbsp;&nbsp;<a href="page211.html">211</a>&nbsp;&nbsp;&nbsp;<a href="page212.html">212</a>&nbsp;&nbsp;&nbsp;<a href="page213.html">213</a>&nbsp;&nbsp;&nbsp;<a href="page214.html">214</a>&nbsp;&nbsp;&nbsp;<a href="page215.html">215</a>
             </td>
             <td width="35%"><a href="page211.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page211.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
